Blue Cross Blue Shield Of Massachusetts To End Coverage Of GLP-1 Medications For Weight Loss

Blue Cross Blue Shield of Massachusetts (BCBSMA) will no longer cover GLP-1 medication for weight loss as part of its standard benefits. The only GLP-1 medications currently approved for weight loss are Wegovy and Zepbound. Other GLP-1s, such as Ozempic and Mounjaro, are approved for the treatment of type 2 diabetes.

While BCBSMA will continue to cover GLP-1 medications as a treatment for diabetes, large employers who choose BCBSMA to administer their plans will have the option to cover or exclude these medications for weight loss.

In February 2025, BCBSMA reported a $400 million operating loss . . .